Illumina, Inc. vs Logitech International SA — how do they compare? Illumina, Inc. trades at $266.99 (market cap $39.95B), while Logitech International SA trades at $101.34 (market cap $14.46B). The key difference: Illumina, Inc. is far larger — about 2.8× Logitech International SA's market cap, and Logitech International SA pays a 1.63% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Illumina, Inc. for 83 Days and Logitech International SA for 92 Days on average.
| ILMN | LOGI | |
|---|---|---|
Market Cap | $39.95B | $14.46B |
Volume | 3,169,503 | 349,547 |
Sector | Health | Technology |
52-Week High | $293.69 | $126.69 |
52-Week Low | $91.00 | $85.84 |
Typical Hold Time | 83 Days | 92 Days |
Enterprise Value | $41.31B | $12.79B |
Dividend Yield | — | 1.63% |
Signals from Pluang's Aura AI — not financial advice
Illumina (ILMN) trades at $267.76, down 2.11% on the day but remains near its 52-week high. The stock exhibits a bullish technical trend with strong moving average signals, while recent earnings beats and a significant return to profitability in 2025 highlight fundamental improvement. Positive sentiment is fueled by S&P 500 inclusion and analyst upgrades, though high valuation ratios present a risk.
The outlook is cautiously optimistic, driven by sequencing growth and AI initiatives, but investors face risks from elevated valuations, competitive pressures, and potential margin volatility. The consensus price target of $241 suggests near-term downside from current levels despite a majority of analysts maintaining a Buy rating.
Logitech (LOGI) trades at $102.18, down slightly (-0.22%) on the day, with a bullish technical signal from moving averages. The company demonstrates strong profitability with a 16.28% net income margin and 35.29% ROE, supported by recent earnings beats. Recent news highlights product launches like the Zone Vibe Pro headset and a partnership with SEGA for Crazy Taxi: World Tour, indicating active business development.
The outlook is cautiously optimistic, with a consensus price target of $107 offering potential upside. Key opportunities include sustained earnings growth and new product cycles, while risks involve competitive pressures in the peripheral market and potential supply chain disruptions, as noted by the CEO addressing chip shortages (WSJ, 2026-09-30).
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →Logitech International SA is a Switzerland-based provider of personal computer and mobile accessories for navigation, video communication, and collaboration, smart home, and other applications. Its product portfolio includes mice, keyboards, charging stands, tablet cases, car mounts for mobile devices, remotes, home cameras, home switches, controllers, bluetooth speakers, surround sound, webcams, and conference cameras. It operates in a single segment namely, Peripherals. The firm generates revenue from the Americas, EMEA (Europe, Middle East, Africa), and the Asia Pacific region.
Read more on LOGI →